145 related articles for article (PubMed ID: 33817849)
1. Integrating a treat to target approach into clinical practice in 2020.
Kennedy NA
J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():6-7. PubMed ID: 33817849
[No Abstract] [Full Text] [Related]
2. Non-invasive biomarkers as treatment targets: What do we all need to know?
Wright E
J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():12-13. PubMed ID: 33817840
[No Abstract] [Full Text] [Related]
3. IBD 2020: Right therapy, right patient, right time - Choosing wisely: Conclusions.
Sparrow M
J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():35-36. PubMed ID: 33817856
[No Abstract] [Full Text] [Related]
4. New models of care in IBD in changing times.
De Cruz P
J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():40-1. PubMed ID: 26989825
[No Abstract] [Full Text] [Related]
5. Ulcerative Colitis in Adults.
Glick LR; Cifu AS; Feld L
JAMA; 2020 Sep; 324(12):1205-1206. PubMed ID: 32857108
[No Abstract] [Full Text] [Related]
6. [Biomarkers in inflammatory bowel diseases].
Roblin X; Cavaille A; Clavel L; Paul S
Presse Med; 2014 Jan; 43(1):66-73. PubMed ID: 24373717
[TBL] [Abstract][Full Text] [Related]
7. The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.
Khanna R; Narula N; Feagan BG
Inflamm Bowel Dis; 2018 Jul; 24(8):1619-1623. PubMed ID: 29846593
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
9. The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
Mago S; Vaziri H; Tadros M
Gastroenterology; 2021 Jun; 160(7):2623-2625. PubMed ID: 32425230
[No Abstract] [Full Text] [Related]
10. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease.
Mozdiak E; O'Malley J; Arasaradnam R
BMJ; 2015 Sep; 351():h4416. PubMed ID: 26403642
[No Abstract] [Full Text] [Related]
12. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
Iborra M; Beltrán B; Nos P
Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
[TBL] [Abstract][Full Text] [Related]
13. [The diagnosis of IBD must have a wide foundation].
Grip O; Halfvarson J; Carlson M; Sternby B
Lakartidningen; 2009 Nov 4-12; 106(45):2984-6. PubMed ID: 19998823
[No Abstract] [Full Text] [Related]
14. Changing treatment paradigms for the management of inflammatory bowel disease.
Im JP; Ye BD; Kim YS; Kim JS
Korean J Intern Med; 2018 Jan; 33(1):28-35. PubMed ID: 29334728
[TBL] [Abstract][Full Text] [Related]
15. [Role of biological markers in inflammatory bowel disease].
Gisbert JP; González-Lama Y; Maté J
Gastroenterol Hepatol; 2007 Mar; 30(3):117-29. PubMed ID: 17374324
[TBL] [Abstract][Full Text] [Related]
16. [Faecal inflammatory markers in nutrition and digestive diseases in children].
Kapel N
Arch Pediatr; 2004 May; 11(5):403-5. PubMed ID: 15135420
[No Abstract] [Full Text] [Related]
17. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?
Gonczi L; Bessissow T; Lakatos PL
World J Gastroenterol; 2019 Nov; 25(41):6172-6189. PubMed ID: 31749591
[TBL] [Abstract][Full Text] [Related]
18. Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.
Plevris N; Chuah CS; Allen RM; Arnott ID; Brennan PN; Chaudhary S; Churchhouse AMD; Din S; Donoghue E; Gaya DR; Groome M; Jafferbhoy HM; Jenkinson PW; Lam WL; Lyons M; Macdonald JC; MacMaster M; Mowat C; Naismith GD; Potts LF; Saffouri E; Seenan JP; Sengupta A; Shasi P; Sutherland DI; Todd JA; Veryan J; Watson AJM; Watts DA; Jones GR; Lees CW
J Crohns Colitis; 2019 Sep; 13(9):1111-1120. PubMed ID: 30768123
[TBL] [Abstract][Full Text] [Related]
19. Thiopurines best practice.
Friedman A
J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():6-7. PubMed ID: 26990458
[No Abstract] [Full Text] [Related]
20. Common mistakes with steroids.
An YK
J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():30-31. PubMed ID: 33817842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
